AI-generated summary
The authors retrospectively reviewed medical charts of 303 patients with medication-related osteonecrosis of the jaw treated at one Italian center between 2004 and 2016, comparing those on bisphosphonates alone with those on antiresorptive-antiangiogenic drugs. They report that the second group was mainly male, with kidney cancer, and that the condition more often arose spontaneously. They also report that surgical laser treatment with Er:YAG seemed to have the highest success rate, and that low-level laser therapy helped outcomes for patients who could not undergo surgery.
- Participants
- 303
- Who or what was studied
- 303 patients (214 females and 89 males, mean age 67 years) treated for medication-related osteonecrosis of the jaw at one center in Parma, Italy, between January 2004 and June 2016
- Limits stated in the abstract
- The study is a single-center retrospective chart review, and the abstract does not describe a control group or formal outcome measures.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on minervamedica.it.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Contraindication. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.